Pharmeceutical company, GlaxoSmithKline Consumer Nigeria Plc said it has concluded arrangements to shut down its operations in Nigeria. The company said
August 03, (THEWILL) - Nigeria’s equities market will lose N55.3 billion market capitalisation following GlaxoSmithKline’s (GSK), plan to close its operations in Nigeria after 51 years. The British multinational .pharmaceutical and biotechnology company which commenced operations in Nigeria in 1972 was listed on the Exchange in 1977. The current market price of the company is
GlaxoSmithKline exits Nigeria after 51 years of operation thestreetjournal.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thestreetjournal.org Daily Mail and Mail on Sunday newspapers.
GlaxoSmithKline, GSK Nigeria to cease operations in Nigeria after evaluating the options for moving to a third-party distribution model for its drugs and consumer healthcare goods. GSK Nigeria, which has faced increased competition from local companies and imports from India and China, said its half-year sales had dropped to 7.75 billion naira ($9.82 million), from 14.8 billion naira in the same period a year ago, Reuters reports.